Optimization of potassium management in patients with chronic kidney disease and type 2 diabetes on finerenone-Reference-Cited by-同舟云学术

Optimization of potassium management in patients with chronic kidney disease and type 2 diabetes on finerenone

Published:2023-05-23 Issue:6 Volume:16 Page:519-531
ISSN:1751-2433
Container-title:Expert Review of Clinical Pharmacology
language:en
Short-container-title:Expert Review of Clinical Pharmacology

Author:

Ortiz Alberto¹^ORCID,Alcázar Arroyo Roberto²,Casado Escribano Pedro Pablo³,Fernández-Fernández Beatriz¹,Martínez Debén Francisco⁴,Mediavilla Juan Diego⁵,Michan-Doña Alfredo⁶^ORCID,Soler Maria Jose⁷,Gorriz Jose Luis⁸^ORCID

Affiliation:

1. Nephrology and Hypertension Department, IIS-FJD and Hospital Universitario Fundación Jiménez Díaz, Madrid, Spain

2. Nephrology Department, Hospital Universitario Infanta Leonor, Madrid, Spain

3. Internal Medicine Department, Hospital Universitario de La Princesa, Madrid, Spain

4. Internal Medicine Department, Hospital Naval, Complexo Hospitalario Universitario de Ferrol. Departamento de Ciencias de la Salud. Universidad de La Coruña, Madrid, Spain

5. Internal Medicine Department, Instituto de Investigación Biosanitaria ibs, Hospital Universitario Virgen de las Nieves, Granada, Spain

6. Department of Medicine, Hospital Universitario de Jerez, Biomedical Research and Innovation Institute of Cadiz (INiBICA), Cádiz, Spain

7. Nephrology Department, Hospital Universitario Vall d‘Hebron, Barcelona, Spain

8. Nephrology Department, Hospital Clínico Universitario de Valencia, Universidad de Valencia, Valencia, Spain

Funder

Bayer Hispania

Instituto de Salud Carlos III

Publisher

Informa UK Limited

Subject

Pharmacology (medical),General Pharmacology, Toxicology and Pharmaceutics,General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/17512433.2023.2213888

Reference96 articles.

1. Clarifying the concept of chronic kidney disease for non-nephrologists

2. Improving the residual risk of renal and cardiovascular outcomes in diabetic kidney disease: A review of pathophysiology, mechanisms, and evidence from recent trials

3. Diabetes with early kidney involvement may shorten life expectancy by 16 years

4. The Effect of Angiotensin-Converting-Enzyme Inhibition on Diabetic Nephropathy

5. Effects of Losartan on Renal and Cardiovascular Outcomes in Patients with Type 2 Diabetes and Nephropathy

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Potential Role of Mineralocorticoid Receptor Antagonists in Nondiabetic Chronic Kidney Disease and Glomerular Disease;Clinical Journal of the American Society of Nephrology;2024-07-22

2. Updates in Chronic Kidney Disease;Journal of Pharmacy Practice;2024-06-14